世界の一般インフルエンザ診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global General Influenza Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4250
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、一般インフルエンザ診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（RIDT、ウイルス培養、DFA、血清学的アッセイ）、用途別市場規模（病院、臨床検査室、その他エンドユーザー）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・一般インフルエンザ診断の市場動向
・企業の競争状況、市場シェア
・一般インフルエンザ診断の種類別市場規模と予測2016-2027（RIDT、ウイルス培養、DFA、血清学的アッセイ）
・一般インフルエンザ診断の用途別市場規模と予測2016-2027（病院、臨床検査室、その他エンドユーザー）
・一般インフルエンザ診断の北米市場規模2016-2027（アメリカ、カナダ）
・一般インフルエンザ診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・一般インフルエンザ診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・一般インフルエンザ診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・一般インフルエンザ診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（F. Hoffmann-La Roche、Quidel Corporation、Thermo Fisher Scientific、Abbott Laboratories、Becton, Dickinson, and Company、DiaSorin、bioMérieux）
・結論

Influenza virus testing is not required to make a clinical diagnosis of Influenza in outpatients with suspected Influenza,Particularly during increased state-run activity when seasonal state-run influenza A and B viruses are circulating in the local community. The traditional detection methods include: RIDT, Viral Culture, DFA, Serological assays.

Market Analysis and Insights: Global General Influenza Diagnostics Market
The global General Influenza Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global General Influenza Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global General Influenza Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global General Influenza Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global General Influenza Diagnostics market.

Global General Influenza Diagnostics Scope and Market Size
General Influenza Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global General Influenza Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
RIDT
Viral Culture
DFA
Serological Assays

Segment by Application
Hospitals
Clinical Laboratories
Other End-User

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffmann-La Roche
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Becton, Dickinson, and Company
DiaSorin
bioMérieux

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global General Influenza Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 RIDT
1.2.3 Viral Culture
1.2.4 DFA
1.2.5 Serological Assays
1.3 Market by Application
1.3.1 Global General Influenza Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Other End-User
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global General Influenza Diagnostics Market Perspective (2016-2027)
2.2 General Influenza Diagnostics Growth Trends by Regions
2.2.1 General Influenza Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 General Influenza Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 General Influenza Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 General Influenza Diagnostics Industry Dynamic
2.3.1 General Influenza Diagnostics Market Trends
2.3.2 General Influenza Diagnostics Market Drivers
2.3.3 General Influenza Diagnostics Market Challenges
2.3.4 General Influenza Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top General Influenza Diagnostics Players by Revenue
3.1.1 Global Top General Influenza Diagnostics Players by Revenue (2016-2021)
3.1.2 Global General Influenza Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global General Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by General Influenza Diagnostics Revenue
3.4 Global General Influenza Diagnostics Market Concentration Ratio
3.4.1 Global General Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by General Influenza Diagnostics Revenue in 2020
3.5 General Influenza Diagnostics Key Players Head office and Area Served
3.6 Key Players General Influenza Diagnostics Product Solution and Service
3.7 Date of Enter into General Influenza Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 General Influenza Diagnostics Breakdown Data by Type
4.1 Global General Influenza Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global General Influenza Diagnostics Forecasted Market Size by Type (2022-2027)

5 General Influenza Diagnostics Breakdown Data by Application
5.1 Global General Influenza Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global General Influenza Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America General Influenza Diagnostics Market Size (2016-2027)
6.2 North America General Influenza Diagnostics Market Size by Type
6.2.1 North America General Influenza Diagnostics Market Size by Type (2016-2021)
6.2.2 North America General Influenza Diagnostics Market Size by Type (2022-2027)
6.2.3 North America General Influenza Diagnostics Market Size by Type (2016-2027)
6.3 North America General Influenza Diagnostics Market Size by Application
6.3.1 North America General Influenza Diagnostics Market Size by Application (2016-2021)
6.3.2 North America General Influenza Diagnostics Market Size by Application (2022-2027)
6.3.3 North America General Influenza Diagnostics Market Size by Application (2016-2027)
6.4 North America General Influenza Diagnostics Market Size by Country
6.4.1 North America General Influenza Diagnostics Market Size by Country (2016-2021)
6.4.2 North America General Influenza Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe General Influenza Diagnostics Market Size (2016-2027)
7.2 Europe General Influenza Diagnostics Market Size by Type
7.2.1 Europe General Influenza Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe General Influenza Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe General Influenza Diagnostics Market Size by Type (2016-2027)
7.3 Europe General Influenza Diagnostics Market Size by Application
7.3.1 Europe General Influenza Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe General Influenza Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe General Influenza Diagnostics Market Size by Application (2016-2027)
7.4 Europe General Influenza Diagnostics Market Size by Country
7.4.1 Europe General Influenza Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe General Influenza Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific General Influenza Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific General Influenza Diagnostics Market Size by Type
8.2.1 Asia-Pacific General Influenza Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific General Influenza Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific General Influenza Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific General Influenza Diagnostics Market Size by Application
8.3.1 Asia-Pacific General Influenza Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific General Influenza Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific General Influenza Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific General Influenza Diagnostics Market Size by Region
8.4.1 Asia-Pacific General Influenza Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific General Influenza Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America General Influenza Diagnostics Market Size (2016-2027)
9.2 Latin America General Influenza Diagnostics Market Size by Type
9.2.1 Latin America General Influenza Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America General Influenza Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America General Influenza Diagnostics Market Size by Type (2016-2027)
9.3 Latin America General Influenza Diagnostics Market Size by Application
9.3.1 Latin America General Influenza Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America General Influenza Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America General Influenza Diagnostics Market Size by Application (2016-2027)
9.4 Latin America General Influenza Diagnostics Market Size by Country
9.4.1 Latin America General Influenza Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America General Influenza Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa General Influenza Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa General Influenza Diagnostics Market Size by Type
10.2.1 Middle East & Africa General Influenza Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa General Influenza Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa General Influenza Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa General Influenza Diagnostics Market Size by Application
10.3.1 Middle East & Africa General Influenza Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa General Influenza Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa General Influenza Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa General Influenza Diagnostics Market Size by Country
10.4.1 Middle East & Africa General Influenza Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa General Influenza Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche General Influenza Diagnostics Introduction
11.1.4 F. Hoffmann-La Roche Revenue in General Influenza Diagnostics Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Quidel Corporation
11.2.1 Quidel Corporation Company Details
11.2.2 Quidel Corporation Business Overview
11.2.3 Quidel Corporation General Influenza Diagnostics Introduction
11.2.4 Quidel Corporation Revenue in General Influenza Diagnostics Business (2016-2021)
11.2.5 Quidel Corporation Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific General Influenza Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Revenue in General Influenza Diagnostics Business (2016-2021)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories General Influenza Diagnostics Introduction
11.4.4 Abbott Laboratories Revenue in General Influenza Diagnostics Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Becton, Dickinson, and Company
11.5.1 Becton, Dickinson, and Company Company Details
11.5.2 Becton, Dickinson, and Company Business Overview
11.5.3 Becton, Dickinson, and Company General Influenza Diagnostics Introduction
11.5.4 Becton, Dickinson, and Company Revenue in General Influenza Diagnostics Business (2016-2021)
11.5.5 Becton, Dickinson, and Company Recent Development
11.6 DiaSorin
11.6.1 DiaSorin Company Details
11.6.2 DiaSorin Business Overview
11.6.3 DiaSorin General Influenza Diagnostics Introduction
11.6.4 DiaSorin Revenue in General Influenza Diagnostics Business (2016-2021)
11.6.5 DiaSorin Recent Development
11.7 bioMérieux
11.7.1 bioMérieux Company Details
11.7.2 bioMérieux Business Overview
11.7.3 bioMérieux General Influenza Diagnostics Introduction
11.7.4 bioMérieux Revenue in General Influenza Diagnostics Business (2016-2021)
11.7.5 bioMérieux Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global General Influenza Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of RIDT
Table 3. Key Players of Viral Culture
Table 4. Key Players of DFA
Table 5. Key Players of Serological Assays
Table 6. Global General Influenza Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global General Influenza Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global General Influenza Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global General Influenza Diagnostics Market Share by Regions (2016-2021)
Table 10. Global General Influenza Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global General Influenza Diagnostics Market Share by Regions (2022-2027)
Table 12. General Influenza Diagnostics Market Trends
Table 13. General Influenza Diagnostics Market Drivers
Table 14. General Influenza Diagnostics Market Challenges
Table 15. General Influenza Diagnostics Market Restraints
Table 16. Global General Influenza Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global General Influenza Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top General Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Influenza Diagnostics as of 2020)
Table 19. Ranking of Global Top General Influenza Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by General Influenza Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players General Influenza Diagnostics Product Solution and Service
Table 23. Date of Enter into General Influenza Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global General Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global General Influenza Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global General Influenza Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global General Influenza Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global General Influenza Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global General Influenza Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global General Influenza Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global General Influenza Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America General Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America General Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America General Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America General Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America General Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America General Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe General Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe General Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe General Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe General Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe General Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe General Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific General Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific General Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific General Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific General Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific General Influenza Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific General Influenza Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America General Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America General Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America General Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America General Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America General Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America General Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa General Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa General Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa General Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa General Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa General Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa General Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. F. Hoffmann-La Roche Company Details
Table 64. F. Hoffmann-La Roche Business Overview
Table 65. F. Hoffmann-La Roche General Influenza Diagnostics Product
Table 66. F. Hoffmann-La Roche Revenue in General Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 67. F. Hoffmann-La Roche Recent Development
Table 68. Quidel Corporation Company Details
Table 69. Quidel Corporation Business Overview
Table 70. Quidel Corporation General Influenza Diagnostics Product
Table 71. Quidel Corporation Revenue in General Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Quidel Corporation Recent Development
Table 73. Thermo Fisher Scientific Company Details
Table 74. Thermo Fisher Scientific Business Overview
Table 75. Thermo Fisher Scientific General Influenza Diagnostics Product
Table 76. Thermo Fisher Scientific Revenue in General Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Thermo Fisher Scientific Recent Development
Table 78. Abbott Laboratories Company Details
Table 79. Abbott Laboratories Business Overview
Table 80. Abbott Laboratories General Influenza Diagnostics Product
Table 81. Abbott Laboratories Revenue in General Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Abbott Laboratories Recent Development
Table 83. Becton, Dickinson, and Company Company Details
Table 84. Becton, Dickinson, and Company Business Overview
Table 85. Becton, Dickinson, and Company General Influenza Diagnostics Product
Table 86. Becton, Dickinson, and Company Revenue in General Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Becton, Dickinson, and Company Recent Development
Table 88. DiaSorin Company Details
Table 89. DiaSorin Business Overview
Table 90. DiaSorin General Influenza Diagnostics Product
Table 91. DiaSorin Revenue in General Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 92. DiaSorin Recent Development
Table 93. bioMérieux Company Details
Table 94. bioMérieux Business Overview
Table 95. bioMérieux General Influenza Diagnostics Product
Table 96. bioMérieux Revenue in General Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 97. bioMérieux Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global General Influenza Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. RIDT Features
Figure 3. Viral Culture Features
Figure 4. DFA Features
Figure 5. Serological Assays Features
Figure 6. Global General Influenza Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinical Laboratories Case Studies
Figure 9. Other End-User Case Studies
Figure 10. General Influenza Diagnostics Report Years Considered
Figure 11. Global General Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global General Influenza Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global General Influenza Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global General Influenza Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global General Influenza Diagnostics Market Share by Players in 2020
Figure 16. Global Top General Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Influenza Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by General Influenza Diagnostics Revenue in 2020
Figure 18. Global General Influenza Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global General Influenza Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America General Influenza Diagnostics Market Share by Type (2016-2027)
Figure 22. North America General Influenza Diagnostics Market Share by Application (2016-2027)
Figure 23. North America General Influenza Diagnostics Market Share by Country (2016-2027)
Figure 24. United States General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe General Influenza Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe General Influenza Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe General Influenza Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific General Influenza Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific General Influenza Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific General Influenza Diagnostics Market Share by Region (2016-2027)
Figure 40. China General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America General Influenza Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America General Influenza Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America General Influenza Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa General Influenza Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa General Influenza Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa General Influenza Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE General Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in General Influenza Diagnostics Business (2016-2021)
Figure 60. Quidel Corporation Revenue Growth Rate in General Influenza Diagnostics Business (2016-2021)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in General Influenza Diagnostics Business (2016-2021)
Figure 62. Abbott Laboratories Revenue Growth Rate in General Influenza Diagnostics Business (2016-2021)
Figure 63. Becton, Dickinson, and Company Revenue Growth Rate in General Influenza Diagnostics Business (2016-2021)
Figure 64. DiaSorin Revenue Growth Rate in General Influenza Diagnostics Business (2016-2021)
Figure 65. bioMérieux Revenue Growth Rate in General Influenza Diagnostics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の犬インフルエンザ検査市場規模・現状・予測（2021年-2027年）

Global Canine Influenza Testing Market Size, Status and Forecast 2021-2027
QFJ1-3961 2021年6月 115Pages
QYResearch社発行の本調査レポートでは、犬インフルエンザ検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗原検査キット、抗体検査キット、その他）、用途別市場規模（施設内販売、獣医診断センター、獣医クリニック、研究所、獣医店）、主要地域別...

世界の分子インフルエンザ検査市場規模・現状・予測（2021年-2027年）

Global Molecular Influenza Test Market Size, Status and Forecast 2021-2027
QFJ1-4525 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、分子インフルエンザ検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（RT-PCR、TMA、LAMP、NASBA、その他）、用途別市場規模（病院、臨床検査室、その他）、主要地域別市場規模（北米、アメリ...

世界の犬インフルエンザ治療市場規模・現状・予測（2021年-2027年）

Global Canine Influenza Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3962 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、犬インフルエンザ治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬（NSAID）、抗ウイルス薬、その他）、用途別市場規模（獣医クリニック、獣医薬局、オンライン薬局、そ...

世界の小児インフルエンザ治療市場規模・現状・予測（2021年-2027年）

Global Pediatric Influenza Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4674 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、小児インフルエンザ治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗ウイルス薬、解熱剤、ノイラミニダーゼ阻害剤、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市...

世界のインフルエンザ治療薬市場規模・現状・予測（2021年-2027年）

Global Influenza Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4367 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、インフルエンザ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ワクチン、医薬品）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界のインフルエンザ用抗ウイルス薬市場規模・現状・予測（2021年-2027年）

Global Influenza Antiviral Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4366 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、インフルエンザ用抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、アダマンタン、その他）、用途別市場規模（病院、クリニック、外科医院、薬局、その他）、...

世界のインフルエンザ用治療薬市場規模・現状・予測（2021年-2027年）

Global Influenza Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5802 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、インフルエンザ用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、...

世界のインフルエンザ (Flu) 抗ウイルス薬市場規模・現状・予測（2021年-2027年）

Global Influenza (Flu) Antiviral Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5801 2021年6月 121Pages
QYResearch社発行の本調査レポートでは、インフルエンザ (Flu) 抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（浸透＆剥離阻害剤、DNAポリメラーゼ阻害剤、逆転写酵素阻害剤、タンパク質阻害剤、ノイラミニダーゼ阻害剤、広域スペ...

世界の創薬＆診断におけるディープラーニング市場規模・現状・予測（2021年-2027年）

Global Deep Learning in Drug Discovery and Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4101 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、創薬＆診断におけるディープラーニングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（創薬、診断、法医学的介入、その他）、用途別市場規模（製薬会社、バイオテクノロジー会社、委託研究機関、医療用IT）、主...

世界の水産養殖における細菌診断市場規模・現状・予測（2021年-2027年）

Global Bacterial Diagnostics in Aquaculture Market Size, Status and Forecast 2021-2027
QFJ1-3884 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、水産養殖における細菌診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（分子診断、蛍光抗体検査、ポリメラーゼ連鎖反応、その他）、用途別市場規模（一般養殖、特別養殖）、主要地域別市場規模（北米、アメリカ...

世界の分子インフルエンザ検査市場規模・現状・予測（2021年-2027年） Rapid molecular assays are a kind of molecular influenza diagnostic test to detect influenza virus nucleic acids in upper respiratory tract specimens with high sensitivity (90-95%) and specificity. FDA-cleared rapid molecular assays are available that produce results in approximately 15-30 minutes. …
世界の糖尿病分析市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diabetic Assays Market The global Diabetic Assays market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a bri…
世界の犬インフルエンザ検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Canine Influenza Testing Market The global Canine Influenza Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
世界の臨床診断PCR市場規模・現状・予測（2021年-2027年） Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials. Market Analysis and Insights: Global Clinical Diagnostics PCR M…
世界のインフルエンザ治療薬市場規模・現状・予測（2021年-2027年） Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus. Market Analysis and Insights: Global Influenza Therapeutics Market The global Influenza Therapeutics market size is projected to reach US$ 9521.1 million by 2027, from US$ 6644.2 million in 2020, at a CAGR o…